Literature DB >> 20425171

Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction?

Daniel W Mudrick1, Eric Velazquez, Salvador Borges-Neto.   

Abstract

Cardiac nuclear imaging studies such as gated single photon emission computed tomography can offer assessment of myocardial perfusion and ventricular function. These two types of data can provide valuable information for the diagnosis of coronary artery disease, prognosis, and optimal treatment strategies. Ejection fraction and other measures of ventricular function generally are the best predictors of mortality, whereas perfusion parameters and estimates of ischemic burden are often the best predictors of nonfatal cardiac events and response to revascularization; the combination of both can provide increased sensitivity and specificity for diagnosis of significant coronary disease, and increased predictive power for outcomes. Recent data show that together they also add incremental value in predicting sudden cardiac death. Less commonly used modalities such as positron emission tomography may offer additional tools for quantification of perfusion and function at rest and at stress, with important clinical implications.

Entities:  

Mesh:

Year:  2010        PMID: 20425171     DOI: 10.1007/s11886-010-0093-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  48 in total

Review 1.  Left ventricular function, myocardial perfusion and viability.

Authors:  Yasuyuki Kobayashi; Albert C Lardo; Yasuo Nakajima; Joao A C Lima; Richard T George
Journal:  Cardiol Clin       Date:  2009-11       Impact factor: 2.213

2.  Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data.

Authors:  P Y Marie; N Danchin; J F Durand; L Feldmann; A Grentzinger; P Olivier; G Karcher; Y Juillière; J M Virion; D Beurrier
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

3.  Incremental value of simultaneous assessment of myocardial function and perfusion with technetium-99m sestamibi for prediction of extent of coronary artery disease.

Authors:  W Palmas; J D Friedman; G A Diamond; H Silber; H Kiat; D S Berman
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

4.  Prediction of death and myocardial infarction by radionuclide angiocardiography in patients with suspected coronary artery disease.

Authors:  S H Johnson; C Bigelow; K L Lee; D B Pryor; R H Jones
Journal:  Am J Cardiol       Date:  1991-05-01       Impact factor: 2.778

5.  Gated myocardial perfusion tomography for the assessment of left ventricular function and volumes: comparison with echocardiography.

Authors:  E Cwajg; J Cwajg; Z X He; W S Hwang; F Keng; S F Nagueh; M S Verani
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

6.  Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease.

Authors:  Salvador Borges-Neto; Linda K Shaw; Robert H Tuttle; John H Alexander; William T Smith; Marianna Chambless; R Edward Coleman; Robert A Harrington; Robert M Califf
Journal:  Am J Cardiol       Date:  2005-01-15       Impact factor: 2.778

7.  Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF.

Authors:  Sharmila Dorbala; Rory Hachamovitch; Zelmira Curillova; Deepak Thomas; Divya Vangala; Raymond Y Kwong; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2009-07

8.  Stress/Rest Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of Cardiac Events in Stable Ischemic Heart Disease.

Authors:  Alessia Gimelli; Giuseppe Rossi; Patrizia Landi; Paolo Marzullo; Giorgio Iervasi; Antonio L'abbate; Daniele Rovai
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

9.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

View more
  3 in total

Review 1.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

2.  Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization.

Authors:  Eric J Velazquez
Journal:  Circ Cardiovasc Imaging       Date:  2012-03       Impact factor: 7.792

3.  Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction.

Authors:  Robert J Mentz; Mona Fiuzat; Linda K Shaw; Afshin Farzaneh-Far; Christopher M O'Connor; Salvador Borges-Neto
Journal:  Open Heart       Date:  2015-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.